112 related articles for article (PubMed ID: 25575863)
1. A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect.
Rana S; Datta K; Reddy TL; Chatterjee E; Sen P; Pal-Bhadra M; Bhadra U; Pramanik A; Pramanik P; Chawla-Sarkar M; Sarkar S
J Control Release; 2015 Feb; 200():167-78. PubMed ID: 25575863
[TBL] [Abstract][Full Text] [Related]
2. Improved bioavailability of targeted Curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment.
Ray A; Rana S; Banerjee D; Mitra A; Datta R; Naskar S; Sarkar S
Toxicol Appl Pharmacol; 2016 Jan; 290():54-65. PubMed ID: 26612707
[TBL] [Abstract][Full Text] [Related]
3. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
4. Nanotized PPARα Overexpression Targeted to Hypertrophied Myocardium Improves Cardiac Function by Attenuating the p53-GSK3β-Mediated Mitochondrial Death Pathway.
Rana S; Datta R; Chaudhuri RD; Chatterjee E; Chawla-Sarkar M; Sarkar S
Antioxid Redox Signal; 2019 Feb; 30(5):713-732. PubMed ID: 29631413
[TBL] [Abstract][Full Text] [Related]
5. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
6. Carboxymethyl chitosan nanoparticles coupled with CD59-specific ligand peptide for targeted delivery of C-phycocyanin to HeLa cells.
Yang P; Li B; Yin QF; Wang YJ
Tumour Biol; 2017 Mar; 39(3):1010428317692267. PubMed ID: 28347253
[TBL] [Abstract][Full Text] [Related]
7. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
8. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
[TBL] [Abstract][Full Text] [Related]
9. pH sensitive alginate-chitosan hydrogel beads for carvedilol delivery.
Meng X; Li P; Wei Q; Zhang HX
Pharm Dev Technol; 2011 Feb; 16(1):22-8. PubMed ID: 20028209
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome c oxidase is essential for copper-induced regression of cardiomyocyte hypertrophy.
Zuo X; Xie H; Dong D; Jiang N; Zhu H; Kang YJ
Cardiovasc Toxicol; 2010 Sep; 10(3):208-15. PubMed ID: 20582486
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-based nanoparticles for mucosal delivery of RNAi therapeutics.
Martirosyan A; Olesen MJ; Howard KA
Adv Genet; 2014; 88():325-52. PubMed ID: 25409611
[TBL] [Abstract][Full Text] [Related]
12. The implications of recent advances in carboxymethyl chitosan based targeted drug delivery and tissue engineering applications.
Upadhyaya L; Singh J; Agarwal V; Tewari RP
J Control Release; 2014 Jul; 186():54-87. PubMed ID: 24806482
[TBL] [Abstract][Full Text] [Related]
13. Peptide decorated calcium phosphate/carboxymethyl chitosan hybrid nanoparticles with improved drug delivery efficiency.
Wang J; Chen B; Zhao D; Peng Y; Zhuo RX; Cheng SX
Int J Pharm; 2013 Mar; 446(1-2):205-10. PubMed ID: 23422273
[TBL] [Abstract][Full Text] [Related]
14. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating.
Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS
Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045
[TBL] [Abstract][Full Text] [Related]
15. Mucoadhesive bilayer buccal tablet of carvedilol-loaded chitosan microspheres: in vitro, pharmacokinetic and pharmacodynamic investigations.
Yedurkar P; Dhiman MK; Petkar K; Sawant K
J Microencapsul; 2012; 29(2):126-37. PubMed ID: 22047549
[TBL] [Abstract][Full Text] [Related]
16. An inhalable β₂-adrenoceptor ligand-directed guanidinylated chitosan carrier for targeted delivery of siRNA to lung.
Luo Y; Zhai X; Ma C; Sun P; Fu Z; Liu W; Xu J
J Control Release; 2012 Aug; 162(1):28-36. PubMed ID: 22698944
[TBL] [Abstract][Full Text] [Related]
17. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
[TBL] [Abstract][Full Text] [Related]
18. Cardiomyocyte-targeted and 17β-estradiol-loaded acoustic nanoprobes as a theranostic platform for cardiac hypertrophy.
Zhao X; Luo W; Hu J; Zuo L; Wang J; Hu R; Wang B; Xu L; Li J; Wu M; Li P; Liu L
J Nanobiotechnology; 2018 Mar; 16(1):36. PubMed ID: 29602311
[TBL] [Abstract][Full Text] [Related]
19. β-Blocker carvedilol protects cardiomyocytes against oxidative stress-induced apoptosis by up-regulating miR-133 expression.
Xu C; Hu Y; Hou L; Ju J; Li X; Du N; Guan X; Liu Z; Zhang T; Qin W; Shen N; Bilal MU; Lu Y; Zhang Y; Shan H
J Mol Cell Cardiol; 2014 Oct; 75():111-21. PubMed ID: 25066695
[TBL] [Abstract][Full Text] [Related]
20. Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles.
Chakraborty S; Shukla D; Vuddanda PR; Mishra B; Singh S
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):563-9. PubMed ID: 20728320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
